Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Lujan-Zilbermann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Fetal and Pediatric Pathology|April 19, 2007
Pediatric HIV infection: diagnostic laboratory methodsJorge Lujan-Zilbermann, Carina A Rodriguez, Patricia J Emmanuel
Fetal and Pediatric Pathology|April 19, 2007
Pediatric HIV infection: immune and viral evaluationCarina A Rodriguez, Jorge Lujan-Zilbermann, Patricia J Emmanuel
AIDS Care|August 6, 2010
Medical decisional capacity among children with HIVTiffany Chenneville, Kimberly Sibille, Jorge Lujan-Zilbermann, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 9, 2018
Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based RecommendationsDeniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, et al.
The Journal of Pediatrics|April 18, 2006
Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasoneSusan R Johnson, Alicia A Marion, Teri Vrchoticky, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
Varicella zoster as a manifestation of immune restoration disease in HIV-infected childrenNutthapong Tangsinmankong, Wasu Kamchaisatian, Jorge Lujan-Zilbermann, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and YouthMeredith G Warshaw, George K Siberry, Paige Williams, et al.
Pediatrics|March 4, 2008
Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infectionAkihiko Saitoh, Marc Foca, Rolando M Viani, et al.
Clinical and Vaccine Immunology : CVI|April 19, 2013
Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youthStephen A Spector, Min Qin, Jorge Lujan-Zilbermann, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2012
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infectionPeter L Havens, Kathleen Mulligan, Rohan Hazra, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Fetal and Pediatric Pathology|April 19, 2007
Pediatric HIV infection: diagnostic laboratory methodsJorge Lujan-Zilbermann, Carina A Rodriguez, Patricia J Emmanuel
Fetal and Pediatric Pathology|April 19, 2007
Pediatric HIV infection: immune and viral evaluationCarina A Rodriguez, Jorge Lujan-Zilbermann, Patricia J Emmanuel
AIDS Care|August 6, 2010
Medical decisional capacity among children with HIVTiffany Chenneville, Kimberly Sibille, Jorge Lujan-Zilbermann, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 9, 2018
Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based RecommendationsDeniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, et al.
The Journal of Pediatrics|April 18, 2006
Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasoneSusan R Johnson, Alicia A Marion, Teri Vrchoticky, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
Varicella zoster as a manifestation of immune restoration disease in HIV-infected childrenNutthapong Tangsinmankong, Wasu Kamchaisatian, Jorge Lujan-Zilbermann, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and YouthMeredith G Warshaw, George K Siberry, Paige Williams, et al.
Pediatrics|March 4, 2008
Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infectionAkihiko Saitoh, Marc Foca, Rolando M Viani, et al.
Clinical and Vaccine Immunology : CVI|April 19, 2013
Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youthStephen A Spector, Min Qin, Jorge Lujan-Zilbermann, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2012
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infectionPeter L Havens, Kathleen Mulligan, Rohan Hazra, et al.
Pageof 2